CIK 0000875045 · Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330112644
- Phone
- 6176792000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 4 Planned sale Director sold 8,760 shares at $150.02 ($1,314,142)
- 3 Insider Initial Statement of Ownership
- 144 Insider Sale of Securities
- 4 Shares withheld for taxes Head of Development gave up 357 shares (to pay taxes)
- 4 Shares withheld for taxes Head of Pharm Ops and Tech gave up 670 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 1,371 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 245 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Human Resources gave up 634 shares (to pay taxes)
- 4 Shares withheld for taxes EVP Chief Legal Officer gave up 807 shares (to pay taxes)
- 4 Shares withheld for taxes Head of Global Product Strat. gave up 445 shares (to pay taxes)
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Shares withheld for taxes Head of Global Product Strat. gave up 1,165 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 1,502 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 3,201 shares (to pay taxes)
- 4 Shares withheld for taxes Head of Research gave up 443 shares (to pay taxes)
Page 7 of 137 · 2,721 filings